S Cotter, R Kidd and O Treacy joined the meeting.
The COO Performance Report and Performance Profile (February Data) which had been circulated prior to the meeting, were noted. The COO confirmed that Regional performance meetings commenced in April. This is an interim process pending the ongoing work on developing a new Performance and Accountability Framework (PAF) which will reflect new governance arrangements and replace prior performance management of hospitals and CHOs from the Centre. The new process is being developed on behalf of the CEO by the Health Regions Programme with input from the incoming National Director, the REOs, Department of Health (DoH) and Department of Children, Equality, Disability, Integration and Youth (DCEDIY). The majority of performance information used relates to February 2024 and any available real time data was also utilised.
The COO updated the Committee on the key strategic and operational updates outlined in the COO Performance Report and Performance Profile, focusing in particular on Scheduled Care, Urgent and Emergency Care, Cancer Services, and Therapy Waiting Lists. The COO advised that overall, performance in February 2024 is better than February 2023 but many target performance metrics for 2024 are being missed.
Regarding Scheduled care, the COO updated the Committee on the 2024 Waiting List, 2024 NSP Targets including focus on patients waiting over 3 Years. He advised that most targets are being achieved but the level of success is being impacted by growth in demand. The COO confirmed that access performance is being actively monitored across HSE Regions and all Regions are finalising their Scheduled Care Plans for 2024.
In relation to Urgent and Emergency Care, the COO updated the Committee on four key UEC metrics: the average 8am weekly trolley count in the year-to-date; the target for patients experience time for people aged over 75; the total number of Delayed Transfers of Care (DTOCs) not to exceed 350; and the average length of stay (LoS) for those over 14 days not exceeding 28 days. The Committee noted there are 8 Hospital/CHOs formally escalated performance under the Performance Accountability Framework (PAF) as the level of improvement required has not been achieved. The COO advised that Performance will be reviewed such that sites will be considered for de-escalation.
Regarding Cancer Services, the Committee were advised that some sites remain in escalation but improvements in performance are being seen, particularly in Cork where all KPIs with the exception of non-urgent breast cancer and radiotherapy are now achieving green rated performance. The COO acknowledged the work completed by the local teams and NCCP in achieving these improvements.
Following a request for update from the Committee, the COO confirmed that the National Radiology Review Steering Group and Working Group were both established in late 2023. The early focus for both groups was the development of a Service Improvement Plan, this draft plan is currently being finalised. The Steering Group and Working Groups have now shifted their focus to the development of a 5 Year National Strategic Plan for Radiology Services. This plan along with the accompanying workforce plan will both be delivered in 2024 and a further update will come to the Committee.
In relation to Therapy Waiting Lists, the Committee discussed the functioning of the current KPIs and advised that there are improvements required to ensure effective performance reflective of the patient and service user perspective. The Committee also queried the mapping of the Health Regions and whether they are effectively aligned with the Children’s Disability Network Teams (CDNTs). The COO advised that this will be aligned unless there are exceptional reasons preventing it and the topic will be included for discussion when Primary Care and ECC is next taken as a focus area by the Committee.
R Kidd left the meeting.